Sensex 27126.57 416.44 1.56%
Nifty 8159.3 129.5 1.61%
Dr. Reddy's Laboratories announced today that it has launched Sildenafil Tablets (20 mg), a bioequivalent generic version of REVATIO® (Sildenafil) Tablets in the US market on November16, 2012, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Sildenafil Tablets.
The REVATIO® brand had U.S. sales of approximately $338.67 Million for the most recent twelve months ending September 2012 according to IMS Health.
Dr. Reddy's Sildenafil Tablets in 20 mg are available in 90 count bottle sizes.
India Infoline News Service / 11:47, Dec 12, 2014
Stepping into a new life comes with a multitude of responsibilities Therefore, it is important to include your spouse in your monetary affairs at the earliest in order to be on common grounds financially.